Literature DB >> 11138926

Inducible nitric oxide synthase in the central nervous system of patients with X-adrenoleukodystrophy.

A G Gilg1, A K Singh, I Singh.   

Abstract

X-Adrenoleukodystrophy (X-ALD) is an inherited peroxisomal disorder of deficient catabolism of very long-chain (VLC) fatty acids with resulting neuroinflammatory demyelinating disease. Our recent documentation of nitric oxide (NO)-mediated increase in VLC fatty acid levels in glial cells and demonstration of greater increase of VLC fatty acids levels in the inflammatory region (plaque) of X-ALD brain as compared to the normal-looking region away from the plaque prompted us to investigate the possible involvement of NO in the pathophysiology of X-ALD. Herein we provide evidence of the expression of inducible nitric oxide synthase (iNOS) in the CNS of X-ALD patients. In situ hybridization demonstrated that iNOS mRNA was present in brain tissues from X-ALD patients but not in normal controls. Double-labeling immunofluorescence studies using cell-specific markers confirmed that iNOS-expressing cells in the CNS of X-ALD were astrocytes and microglia/macrophages. Finally, antibodies against nitrotyrosine strongly immunoreacted with tissues from the center of the plaque region of X-ALD brains suggesting the presence of the NO reaction product nitrotyrosine in the CNS of X-ALD. Taken together, these results demonstrate that iNOS is expressed in the brains of patients with X-ALD and may contribute to the pathogenesis of the disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11138926     DOI: 10.1093/jnen/59.12.1063

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  24 in total

1.  ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy.

Authors:  Mauhamad Baarine; Craig Beeson; Avtar Singh; Inderjit Singh
Journal:  J Neurochem       Date:  2015-01-13       Impact factor: 5.372

Review 2.  Current and future pharmacological treatment strategies in X-linked adrenoleukodystrophy.

Authors:  Johannes Berger; Aurora Pujol; Patrick Aubourg; Sonja Forss-Petter
Journal:  Brain Pathol       Date:  2010-07       Impact factor: 6.508

Review 3.  Pathomechanisms underlying X-adrenoleukodystrophy: a three-hit hypothesis.

Authors:  Inderjit Singh; Aurora Pujol
Journal:  Brain Pathol       Date:  2010-07       Impact factor: 6.508

4.  Dendrimer-N-acetyl-L-cysteine modulates monophagocytic response in adrenoleukodystrophy.

Authors:  Bela R Turk; Christina L Nemeth; Joel S Marx; Carol Tiffany; Richard Jones; Benjamin Theisen; Siva Kambhampati; Raj Ramireddy; Sarabdeep Singh; Melissa Rosen; Miriam L Kaufman; Connor F Murray; Paul A Watkins; Sujatha Kannan; Rangaramanujam Kannan; Ali Fatemi
Journal:  Ann Neurol       Date:  2018-09       Impact factor: 10.422

5.  Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy.

Authors:  Jorge Galino; Montserrat Ruiz; Stéphane Fourcade; Agatha Schlüter; Jone López-Erauskin; Cristina Guilera; Mariona Jove; Alba Naudi; Elena García-Arumí; Antoni L Andreu; Anatoly A Starkov; Reinald Pamplona; Isidre Ferrer; Manuel Portero-Otin; Aurora Pujol
Journal:  Antioxid Redox Signal       Date:  2011-06-08       Impact factor: 8.401

Review 6.  Oxidative Stress in Patients with X-Linked Adrenoleukodystrophy.

Authors:  Marion Deon; Desirèe P Marchetti; Bruna Donida; Moacir Wajner; Carmen Vargas
Journal:  Cell Mol Neurobiol       Date:  2015-07-14       Impact factor: 5.046

7.  Spatiotemporal patterns of dexamethasone-induced Ras protein 1 expression in the central nervous system of rats with experimental autoimmune encephalomyelitis.

Authors:  Heng Gao; Ying Gao; Xiaohong Li; Aiguo Shen; Meijuan Yan
Journal:  J Mol Neurosci       Date:  2010-01-19       Impact factor: 3.444

8.  Oxidative imbalance in nonstimulated X-adrenoleukodystrophy-derived lymphoblasts.

Authors:  Takuhiro Uto; Miguel A Contreras; Anne G Gilg; Inderjit Singh
Journal:  Dev Neurosci       Date:  2009-01-07       Impact factor: 2.984

Review 9.  "Lorenzo's oil" therapy for X-linked adrenoleukodystrophy: rationale and current assessment of efficacy.

Authors:  Hugo W Moser; Ann B Moser; Kim Hollandsworth; N Hong Brereton; Gerald V Raymond
Journal:  J Mol Neurosci       Date:  2007-09       Impact factor: 3.444

10.  Detection and Quantification of Free Radicals in Peroxisomal Disorders: A Comparative Study with Oxidative Stress Parameters.

Authors:  Sohair Abd-El Mawgood Abd-Elmaksoud; Hala El-Bassyouni; Hanan Afifi; Manal Micheal Thomas; Alshaymaa Ahmed Ibrahim; Aliaa Shalaby; Tamer Ahmed Abdel Hamid; Nehal Abdel Hamid; Hany El-Ghobary
Journal:  J Clin Diagn Res       Date:  2015-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.